Vor Biopharma Inc. · NASDAQ:VOR
Ra Capital Management, L.P. sold 630,374 Vor Biopharma Inc. shares (Form 4)
Traded Apr 17 to Apr 20, 2026 · Filed Apr 21, 2026
From Apr 17 to Apr 20, 2026, Ra Capital Management, L.P. (Director, 10% owner) sold 630,374 Vor Biopharma Inc. shares at an average US$16.14 for US$10.2M, leaving 2,567,245 shares. Filed Apr 21, 2026 (Form 4).
- Sold
- 630,374 shares
- Price
- US$16.14 average (US$15.77 to US$16.28)
- Value
- US$10.2M
- Holding after
- 2,567,245 shares (held indirectly)
- Trading plan
- No
- Role
- Director, 10% owner
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 17, 2026 | Common Stock | Sale | 458,411 | US$16.28 | 2,739,208 | Indirect |
| Apr 20, 2026 | Common Stock | Sale | 171,963 | US$15.77 | 2,567,245 | Indirect |
Source
Related
- Vor Biopharma Inc.
- Ra Capital Management, L.P.
- Vor Biopharma Inc. shareholders
- Form 4 · Ra Capital Management, L.P. · Oct 5, 2026
- Form 4 · Ra Capital Management, L.P. · Apr 15, 2026
- Form 4 · RA Capital Healthcare Fund LP · Aug 26, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Frazier Life Sciences Public Fund, L.P. · Aug 14, 2026
- Schedule 13G/A · Verve Capital Limited · Aug 13, 2026
- Schedule 13G/A · FMR LLC · Aug 7, 2026